Results 221 to 230 of about 82,568 (267)
Cannabis Use and Cannabis Use Disorder
Nature Reviews Disease Primers, 2021 Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global ...
Alan Budney +2 more
exaly +8 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cannabis and Cannabis Edibles: A Review
Journal of Agricultural and Food Chemistry, 2021Cannabis is an excellent natural source of fiber and various bioactive cannabinoids. So far, at least 120 cannabinoids have been identified, and more novel cannabinoids are gradually being unveiled by detailed cannabis studies. However, cannabinoids in both natural and isolated forms are especially vulnerable to oxygen, heat, and light.
Han Peng, Fereidoon Shahidi
openaire +2 more sources
Cannabis and Cannabis Extracts
Journal of Cannabis Therapeutics, 2001SUMMARY. A central tenet underlying the use of botanical remedies is that herbs contain many active ingredients. Primary active ingredients may be enhanced by secondary compounds, which act in beneficial synergy. Other herbal constituents may mitigate the side effects of dominant active ingredients.
John M. McPartland, Ethan B. Russo
openaire +1 more source
Cannabis and cannabis withdrawal
Journal of Substance Misuse, 1997Cannabis, or marijuana, has been the subject of much controversy. The authors discuss the neuropharmacology of tetrahydrocannabinol (THC). They relate the recent identification of a THC receptor site in the brain and its possible relevance to the existence of a marijuana withdrawal syndrome. Such a withdrawal syndrome is described. The authors conclude
D. E. Smith, R. B. Seymour
openaire +1 more source
Journal of Occupational & Environmental Medicine
Objective Cannabis use is expanding rapidly, and a guideline is needed to address workplace issues. Methods The ACOEM Guidelines methodology was used to develop an evidence-based guideline.
Steven D. Feinberg +15 more
openaire +2 more sources
Objective Cannabis use is expanding rapidly, and a guideline is needed to address workplace issues. Methods The ACOEM Guidelines methodology was used to develop an evidence-based guideline.
Steven D. Feinberg +15 more
openaire +2 more sources
The Toxicology of Cannabis and Cannabis Prohibition
ChemInform, 2007AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
openaire +2 more sources
Cultivating Cannabis, Excepting Cannabis
2021Cannabis is often framed as an exception to the War on Drugs. Legalization would simply remove “soft drugs” from prohibition while leaving the rest of the drug war apparatus in place. This “cannabis exceptionalism,” however, elides the centrality of cannabis in the global drug war.
openaire +1 more source
BMJ, 2017
Evidence supports reform to allow the legitimate study, regulation, and prescription of therapeutic ...
openaire +2 more sources
Evidence supports reform to allow the legitimate study, regulation, and prescription of therapeutic ...
openaire +2 more sources
2020
Cultivation and breeding of Cannabis sativa L. for medicinal purposes is of actual importance since in many countries the legalization allows its use by patients. So far, Cannabis sativa L. and its various strains, optimized for their cannabinoids, have mostly been bred and cultivated under illegal conditions to provide an illicit drug without ...
Paweł Rodziewicz, Oliver Kayser
openaire +1 more source
Cultivation and breeding of Cannabis sativa L. for medicinal purposes is of actual importance since in many countries the legalization allows its use by patients. So far, Cannabis sativa L. and its various strains, optimized for their cannabinoids, have mostly been bred and cultivated under illegal conditions to provide an illicit drug without ...
Paweł Rodziewicz, Oliver Kayser
openaire +1 more source
Cannabis & Cannabinoid Research, 2023
The World Anti-Doping Agency (WADA) classifies cannabis, all phytocannabinoids, and synthetics as doping, except for CBD. For agency, a method for doping substance must meet two criteria: performance enhancement (ergogenicity), health risk, or violation of the spirit of sports.
openaire +2 more sources
The World Anti-Doping Agency (WADA) classifies cannabis, all phytocannabinoids, and synthetics as doping, except for CBD. For agency, a method for doping substance must meet two criteria: performance enhancement (ergogenicity), health risk, or violation of the spirit of sports.
openaire +2 more sources